Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Winnipeg Lab

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Mar 15, 2021 8:28pm

154 Views

Post# 32804741

RE:RE:RE:RE:Winnipeg Lab

Starting a trial is one of the pieces of news we are hoping to see in the near future.

99942Apophis wrote: For a list of Canadian Covid-19 clinical trials search has 8 pages and there isn't any listing for TLD-1433 or U of M, Dr. Coombs or Theralase

Drugs and vaccines for COVID-19: List of authorized clinical trials